No headlines found.
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
Business Wire (Tue, 6-Jan 7:00 AM ET)
PureTech Appoints Robert Lyne as Chief Executive Officer
Business Wire (Thu, 18-Dec 2:00 AM ET)
Business Wire (Mon, 8-Dec 2:00 AM ET)
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
Puretech Health PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol PRTC.
As of February 5, 2026, PRTC stock price was flat at $18.50 with 364 million shares trading.
PRTC has a market cap of $447.12 million. This is considered a Small Cap stock.
In the last 3 years, PRTC traded as high as $35.06 and as low as $13.30.
PRTC has underperformed the market in the last year with a return of -4.4%, while SPY returned +13.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PRTC shares. However, PRTC has outperformed the market in the last 3 month and 2 week periods, returning +8.2% and +6.9%, while SPY returned +0.6% and -1.1%, respectively. This indicates PRTC has been having a stronger performance recently.
PRTC support price is $17.59 and resistance is $19.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRTC shares will trade within this expected range on the day.
